4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-18-054056
President and CEO sold 18,333 shares at $21.72 ($398,193)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2018-10-01 | Sale | −18,333 | $21.72 | $398,193 | 2,747,638 | I |
| Open-market sales · 18,333 sh · avg $21.72 · $398,193 | |||||||
Loading xslF345X03/doc4.xml…